Results 51 to 60 of about 1,346,069 (268)

In vitro models of proarrhythmia [PDF]

open access: yesBritish Journal of Pharmacology, 2008
Proarrhythmia models use electrophysiological markers to predict the risk of torsade de pointes (TdP) in patients. The set of variables used by each model to predict the torsadogenic propensity of a drug has been reported to correlate with clinical outcome; however, these reports should be interpreted cautiously as no model has been independently ...
C L, Lawrence   +3 more
openaire   +2 more sources

Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential

open access: yesFEBS Letters, EarlyView.
Aging reshapes the gut microbiome (↓SCFA‐producing commensals; ↑pro‐inflammatory outputs), shifting circulating metabolites (↓SCFAs; ↑LPS, ↑TMAO, ↑PAA) that act at the BBB to increase nonspecific transcytosis, alter transport, and promote astrocyte reactivity, heightening brain vulnerability.
Daniel Cuervo‐Zanatta   +3 more
wiley   +1 more source

The Future Exploring of Gut Microbiome-Immunity Interactions: From In Vivo/Vitro Models to In Silico Innovations

open access: yesMicroorganisms
Investigating the complex interactions between microbiota and immunity is crucial for a fruitful understanding progress of human health and disease. This review assesses animal models, next-generation in vitro models, and in silico approaches that are ...
Sara Bertorello   +4 more
doaj   +1 more source

Structure‐forward targeting of claudins with synthetic binders

open access: yesFEBS Letters, EarlyView.
Claudins form the paracellular barriers between epithelial and endothelial tissues at tight junctions and are targets for molecular binders with the goal of modulating barrier permeability. Claudin‐binding molecules are relevant in drug delivery or in altering claudin interactions with disease‐causing proteins.
Alex J. Vecchio
wiley   +1 more source

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

open access: yesFEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang   +2 more
wiley   +1 more source

Welcome to In vitro models [PDF]

open access: yesIn vitro models, 2021
J Miguel, Oliveira, Ketul C, Popat
openaire   +2 more sources

Organoids: a better in vitro model [PDF]

open access: yesNature Methods, 2017
3D human cell cultures are changing the way scientists model organ development and function—but they have their own set of complications.
openaire   +2 more sources

Liver organoids: modelling complexity in homeostasis and disease

open access: yesFEBS Letters, EarlyView.
Studying liver in vitro has been challenging because simple 2D cell cultures fail to capture liver's cellular and architectural complexity. To bridge this gap, scientists increasingly use organoids, 3D liver models which better mimic liver composition and function. This review examines recent advances in liver organoid complexity and realism, discusses
Anna M. Dowbaj, Meritxell Huch
wiley   +1 more source

Pre- and post-copulatory traits are affected by experimental inbreeding, but they are not correlated

open access: yesBMC Biology
Background It has been suggested that the expression of males’ secondary sexual traits provides reliable indicators of their sperm traits, predicting positive correlations between pre- and post-copulatory traits (Fertility Indicator Hypothesis).
Doris Nicolakis   +4 more
doaj   +1 more source

Analytical and computational studies predict negligible risk of cell death from eddy generation off flat surfaces in cell culture flow systems

open access: yesFrontiers in Bioengineering and Biotechnology
Cell-based therapies represent the current frontier of biomedical innovations, with the technologies required underpinning treatments as broad as CAR-T cell therapies, stem cell treatments, genetic therapies and mRNA manufacture.
Elliot J. Morley   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy